218 related articles for article (PubMed ID: 33944777)
21. Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1.
Loreto A; Angeletti C; Gu W; Osborne A; Nieuwenhuis B; Gilley J; Merlini E; Arthur-Farraj P; Amici A; Luo Z; Hartley-Tassell L; Ve T; Desrochers LM; Wang Q; Kobe B; Orsomando G; Coleman MP
Elife; 2021 Dec; 10():. PubMed ID: 34870595
[TBL] [Abstract][Full Text] [Related]
22. SARM1 regulates NAD
Shanahan KA; Davis GM; Doran CG; Sugisawa R; Davey GP; Bowie AG
J Biol Chem; 2024 Feb; 300(2):105620. PubMed ID: 38176648
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy targeting SARM1 blocks pathological axon degeneration in mice.
Geisler S; Huang SX; Strickland A; Doan RA; Summers DW; Mao X; Park J; DiAntonio A; Milbrandt J
J Exp Med; 2019 Feb; 216(2):294-303. PubMed ID: 30642945
[TBL] [Abstract][Full Text] [Related]
24. Novel role of SARM1 mediated axonal degeneration in the pathogenesis of rabies.
Sundaramoorthy V; Green D; Locke K; O'Brien CM; Dearnley M; Bingham J
PLoS Pathog; 2020 Feb; 16(2):e1008343. PubMed ID: 32069324
[TBL] [Abstract][Full Text] [Related]
25. Axons Matter: The Promise of Treating Neurodegenerative Disorders by Targeting SARM1-Mediated Axonal Degeneration.
Krauss R; Bosanac T; Devraj R; Engber T; Hughes RO
Trends Pharmacol Sci; 2020 Apr; 41(4):281-293. PubMed ID: 32107050
[TBL] [Abstract][Full Text] [Related]
26. NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD
Sasaki Y; Nakagawa T; Mao X; DiAntonio A; Milbrandt J
Elife; 2016 Oct; 5():. PubMed ID: 27735788
[TBL] [Abstract][Full Text] [Related]
27. Uncompetitive, adduct-forming SARM1 inhibitors are neuroprotective in preclinical models of nerve injury and disease.
Bratkowski M; Burdett TC; Danao J; Wang X; Mathur P; Gu W; Beckstead JA; Talreja S; Yang YS; Danko G; Park JH; Walton M; Brown SP; Tegley CM; Joseph PRB; Reynolds CH; Sambashivan S
Neuron; 2022 Nov; 110(22):3711-3726.e16. PubMed ID: 36087583
[TBL] [Abstract][Full Text] [Related]
28. The SARM1 TIR domain produces glycocyclic ADPR molecules as minor products.
Garb J; Amitai G; Lu A; Ofir G; Brandis A; Mehlman T; Kranzusch PJ; Sorek R
PLoS One; 2024; 19(4):e0302251. PubMed ID: 38635746
[TBL] [Abstract][Full Text] [Related]
29. c-Jun N-terminal kinase (JNK)-mediated phosphorylation of SARM1 regulates NAD
Murata H; Khine CC; Nishikawa A; Yamamoto KI; Kinoshita R; Sakaguchi M
J Biol Chem; 2018 Dec; 293(49):18933-18943. PubMed ID: 30333228
[TBL] [Abstract][Full Text] [Related]
30. Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.
Geisler S; Doan RA; Cheng GC; Cetinkaya-Fisgin A; Huang SX; Höke A; Milbrandt J; DiAntonio A
JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484833
[TBL] [Abstract][Full Text] [Related]
31. A conformation-specific nanobody targeting the nicotinamide mononucleotide-activated state of SARM1.
Hou YN; Cai Y; Li WH; He WM; Zhao ZY; Zhu WJ; Wang Q; Mai X; Liu J; Lee HC; Stjepanovic G; Zhang H; Zhao YJ
Nat Commun; 2022 Dec; 13(1):7898. PubMed ID: 36550129
[TBL] [Abstract][Full Text] [Related]
32. Identification of the first noncompetitive SARM1 inhibitors.
Loring HS; Parelkar SS; Mondal S; Thompson PR
Bioorg Med Chem; 2020 Sep; 28(18):115644. PubMed ID: 32828421
[TBL] [Abstract][Full Text] [Related]
33. Context-Specific Stress Causes Compartmentalized SARM1 Activation and Local Degeneration in Cortical Neurons.
Hinz FI; Villegas CLM; Roberts JT; Yao H; Gaddam S; Delwig A; Green SA; Fredrickson C; Adrian M; Asuncion RR; Cheung TK; Hayne M; Hackos DH; Rose CM; Richmond D; Hoogenraad CC
J Neurosci; 2024 Jun; 44(24):. PubMed ID: 38692735
[TBL] [Abstract][Full Text] [Related]
34. SARM1 deficiency promotes rod and cone photoreceptor cell survival in a model of retinal degeneration.
Ozaki E; Gibbons L; Neto NG; Kenna P; Carty M; Humphries M; Humphries P; Campbell M; Monaghan M; Bowie A; Doyle SL
Life Sci Alliance; 2020 May; 3(5):. PubMed ID: 32312889
[TBL] [Abstract][Full Text] [Related]
35. Autophagy protein ULK1 interacts with and regulates SARM1 during axonal injury.
Choi HMC; Li Y; Suraj D; Hsia RC; Sarkar C; Wu J; Lipinski MM
Proc Natl Acad Sci U S A; 2022 Nov; 119(47):e2203824119. PubMed ID: 36375051
[TBL] [Abstract][Full Text] [Related]
36. Sarm1 loss reduces axonal damage and improves cognitive outcome after repetitive mild closed head injury.
Maynard ME; Redell JB; Zhao J; Hood KN; Vita SM; Kobori N; Dash PK
Exp Neurol; 2020 May; 327():113207. PubMed ID: 31962129
[TBL] [Abstract][Full Text] [Related]
37. The NAD
Llobet Rosell A; Paglione M; Gilley J; Kocia M; Perillo G; Gasparrini M; Cialabrini L; Raffaelli N; Angeletti C; Orsomando G; Wu PH; Coleman MP; Loreto A; Neukomm LJ
Elife; 2022 Dec; 11():. PubMed ID: 36476387
[TBL] [Abstract][Full Text] [Related]
38. SARM1 is required in human derived sensory neurons for injury-induced and neurotoxic axon degeneration.
Chen YH; Sasaki Y; DiAntonio A; Milbrandt J
Exp Neurol; 2021 May; 339():113636. PubMed ID: 33548217
[TBL] [Abstract][Full Text] [Related]
39. Protective effects of NAMPT or MAPK inhibitors and NaR on Wallerian degeneration of mammalian axons.
Alexandris AS; Ryu J; Rajbhandari L; Harlan R; McKenney J; Wang Y; Aja S; Graham D; Venkatesan A; Koliatsos VE
Neurobiol Dis; 2022 Sep; 171():105808. PubMed ID: 35779777
[TBL] [Abstract][Full Text] [Related]
40. Live imaging reveals the cellular events downstream of SARM1 activation.
Ko KW; Devault L; Sasaki Y; Milbrandt J; DiAntonio A
Elife; 2021 Nov; 10():. PubMed ID: 34779400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
